Grab (NASDAQ:GRAB) vs. Lifeward (NASDAQ:LFWD) Financial Review

Grab (NASDAQ:GRABGet Free Report) and Lifeward (NASDAQ:LFWDGet Free Report) are both computer and technology companies, but which is the better business? We will contrast the two companies based on the strength of their analyst recommendations, risk, dividends, profitability, earnings, valuation and institutional ownership.

Profitability

This table compares Grab and Lifeward’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Grab 3.81% 1.91% 1.19%
Lifeward -121.82% -183.18% -109.28%

Risk & Volatility

Grab has a beta of 0.89, meaning that its share price is 11% less volatile than the S&P 500. Comparatively, Lifeward has a beta of 0.01, meaning that its share price is 99% less volatile than the S&P 500.

Insider & Institutional Ownership

55.5% of Grab shares are held by institutional investors. Comparatively, 26.8% of Lifeward shares are held by institutional investors. 3.6% of Grab shares are held by company insiders. Comparatively, 2.7% of Lifeward shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Grab and Lifeward”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Grab $2.80 billion 7.85 -$105.00 million $0.04 136.25
Lifeward $25.66 million 0.41 -$28.94 million ($2.97) -0.20

Lifeward has lower revenue, but higher earnings than Grab. Lifeward is trading at a lower price-to-earnings ratio than Grab, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of recent ratings for Grab and Lifeward, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Grab 0 4 5 0 2.56
Lifeward 1 0 3 0 2.50

Grab currently has a consensus target price of $6.37, suggesting a potential upside of 16.91%. Lifeward has a consensus target price of $6.17, suggesting a potential upside of 945.20%. Given Lifeward’s higher probable upside, analysts plainly believe Lifeward is more favorable than Grab.

Summary

Grab beats Lifeward on 12 of the 14 factors compared between the two stocks.

About Grab

(Get Free Report)

Grab Holdings Limited engages in the provision of superapps in Cambodia, Indonesia, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Vietnam. The company offers its Grab ecosystem, a single platform with superapps for driver- and merchant-partners and consumers, that allows access to mobility, delivery, digital financial services, and enterprise sector offerings. Grab Holdings Limited is headquartered in Singapore.

About Lifeward

(Get Free Report)

ReWalk Robotics Ltd., a medical device company, designs, develops, and commercializes technologies that enable mobility and wellness in rehabilitation and daily life for individuals with physical and neurological conditions in the United States, Europe, the Asia-Pacific, and internationally. It offers ReWalk personal exoskeleton and rehabilitation exoskeleton devices; ReStore, a soft exo-suit intended for use in the rehabilitation of individuals with lower limb disability due to stroke; AlterG Anti-Gravity System for use in physical and neurological rehabilitation and athletic training; MyoCycle devices; and ReBoot, a personal soft exo-suit for home and community use by individuals post-stroke. The company markets and sells its products directly to institutions and individuals, as well as through third-party distributors. The company was formerly known as Argo Medical Technologies Ltd. ReWalk Robotics Ltd. was incorporated in 2001 and is headquartered in Yokneam Illit, Israel.

Receive News & Ratings for Grab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grab and related companies with MarketBeat.com's FREE daily email newsletter.